Liquid chromatographic evaluation of purine production in the donor human heart during transplantation.

A reversed phase high performance liquid chromatographic technique is presented allowing purine catabolite determination in a whole blood extract without a prior purification step. The method was applied to determine the timing and the profile of myocardial nucleotide catabolite release during reperfusion of the transplanted human heart. Samples of arterial and coronary sinus blood collected at various times within 1 h after aortic declamping during heart or heart-lung transplantations were used for nucleotide catabolite determination. Massive release of inosine and hypoxanthine from the heart was demonstrated. Production of adenosine was also shown but there was no liberation of xanthine or uric acid. Nucleotide catabolite release was greatest in the first 5 min (coronary sinus-arterial difference = 15-20 microM), but was still significant after 30 min of reperfusion. The determination of inosine and hypoxanthine--major catabolites released--was found to be reproducible in coronary sinus blood (coefficient of variation < 10%). However, immediate protein precipitation afer blood sample collection was necessary, as rapid metabolism of both exogenous and endogenous adenosine and inosine was demonstrated.

[1]  R. Ferrari,et al.  Do the stress proteins influence the mitochondrial functions , 1992 .

[2]  R. Ferrari,et al.  Relation between energy metabolism, glycolysis, noradrenaline and duration of ischaemia , 1992 .

[3]  M. Yacoub,et al.  Adenine nucleotide catabolism in human myocardium during heart and heart-lung transplantation. , 1992, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[4]  J. Schrader,et al.  Oxygen partial pressure and free intracellular adenosine of isolated cardiomyocytes. , 1991, The American journal of physiology.

[5]  R. Jones,et al.  Recovery of myocardial function during coronary artery bypass grafting. Intraoperative assessment by pressure-volume loops. , 1991, The Journal of thoracic and cardiovascular surgery.

[6]  R. Smolenski,et al.  Purines, lactate and phosphate release from child and adult heart during cardioplegic arrest. , 1990, Clinica chimica acta; international journal of clinical chemistry.

[7]  G. van Es,et al.  Myocardial protection by intravenous diltiazem during angioplasty of single-vessel coronary artery disease. , 1990, The American journal of cardiology.

[8]  R. Smolenski,et al.  Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. , 1990, Journal of chromatography.

[9]  P. Serruys,et al.  Urate production by human heart. , 1989, Journal of molecular and cellular cardiology.

[10]  A. Składanowski,et al.  Adenylate degradation products release from the human myocardium during open heart surgery. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[11]  J. Schrader,et al.  Turnover of adenosine in plasma of human and dog blood. , 1989, The American journal of physiology.

[12]  M. Mariani,et al.  Uric acid and purine compounds in aortic and coronary sinus blood in man. , 1989, Advances in experimental medicine and biology.

[13]  J. Schrader,et al.  Formation of S-adenosylhomocysteine in the heart. II: A sensitive index for regional myocardial underperfusion. , 1988, Circulation research.

[14]  J. D. Jong Diagnosis of Ischemic Heart Disease with AMP-Catabolites , 1988 .

[15]  E. Harmsen,et al.  The Importance of the Determination of ATP and Catabolites , 1988 .

[16]  G. J. Vusse,et al.  Myocardial High-Energy Phosphates during Open-Heart Surgery , 1988 .

[17]  S. Soboll,et al.  Cytosolic adenylates and adenosine release in perfused working heart. Comparison of whole tissue with cytosolic non-aqueous fractionation analyses. , 1986, European journal of biochemistry.

[18]  H. Simmonds,et al.  Use of a fundamental elution protocol for the development of reversed-phase high-performance liquid chromatography enabling rapid simultaneous determination of purines, pyrimidines and allied compounds commonly found in human biological fluids. , 1985, Journal of chromatography.

[19]  R. Jennings,et al.  Pathobiology of acute myocardial ischemia: metabolic, functional and ultrastructural studies. , 1983, The American journal of cardiology.

[20]  D. Adams,et al.  Evidence that ischemic cell death begins in the subendocardium independent of variations in collateral flow or wall tension. , 1983, Circulation.

[21]  A. Gage,et al.  Perioperative preservation of myocardial ultrastructure and high-energy phosphates in man. , 1981, The Journal of thoracic and cardiovascular surgery.

[22]  P. Serruys,et al.  Hypoxanthine production by ischemic heart demonstrated by high pressure liquid chromatography of blood purine nucleosides and oxypurines. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[23]  F. Spencer,et al.  Preservation of ATP, ultrastructure, and ventricular function after aortic cross-clamping and reperfusion. Clinical use of blood potassium cardioplegia. , 1979, The Journal of thoracic and cardiovascular surgery.

[24]  G E Reed,et al.  Release of nucleosides from canine and human hearts as an index of prior ischemia. , 1979, The American journal of cardiology.